tirzepatide glp gip Tirzepatide's Unique Mechanism of Action - GIP/GLP-1 Dual Agonist Tirzepatide is a first-in-class dual

It has also been found that, in addition to effectively treating diabetes and obesity, semaglutide, tirzepatide, and similar drugs reduce the risk of heart attacks, strokes, and death from cardiovascular causes by 20%

Odd-chain fatty acids represent a small fraction of dietary fat intake

STUDY FINDS SEMAGLUTIDE REDUCES ALCOHOL CONSUMPTION IN OBESE PATIENTS WITH ALCOHOL USE DISORDER May 2026 A small, placebo-controlled trial showed that semaglutide reduced heavy drinking days in obese patients The issue: Alcohol use disorder (AUD) is common but lacks a highly effective treatment

Among the substitute GLP-1 receptor agonists are: Albiglutide (Tanzeum) Exenatide (Bydureon, Byetta) Dulaglutide (Trulicity) Liraglutide (Saxenda, Victoza) These medications offer a range of options for individuals seeking alternatives to semaglutide, ensuring flexibility in obesity and diabetes management based on personal preferences and healthcare provider recommendations

Alzheimers disease (AD), the most common form of dementia worldwide 270,271 , is characterized at the molecular level by the accumulation of A plaques, tau neurofibrillary tangles (NFTs), declined NAD + levels, mitochondrial stress, and impaired mitophagy, occurring first in the medial temporal lobe and eventually spreading to temporal and parietal cortices, and cortex 112,242,243,270,271,272

Each plan includes monthly consultations, metabolic lab testing, and real-time progress tracking